Clinical Outcome of Conversion Surgery for Stage IV Esophageal Cancer Following Chemoradiation. [PDF]
Wang HC+8 more
europepmc +1 more source
Identification of biomarkers and potential drug targets for esophageal cancer: a Mendelian randomization study. [PDF]
Li C, Cui X, Ren M, Yin Y, He S.
europepmc +1 more source
Causes of Postsurgical Pulmonary Complications in Patients with Esophageal Cancer.
Kazuhisa Shiroyama+5 more
openalex +2 more sources
Application of modified neck drainage in the management of cervical anastomotic fistula in esophageal cancer patients. [PDF]
Wu S, Zhang Z, Qin Z.
europepmc +1 more source
A CASE REPORT OF ONE STAGED OPERATION OF THORACIC ESOPHAGEAL CANCER IN AN 88-YEAR-OLD PATIENT
Takumi Sasai+5 more
openalex +2 more sources
Breaking barriers: Smart vaccine platforms for cancer immunomodulation
Abstract Despite significant advancements in cancer treatment, current therapies often fail to completely eradicate malignant cells. This shortfall underscores the urgent need to explore alternative approaches such as cancer vaccines. Leveraging the immune system's natural ability to target and kill cancer cells holds great therapeutic potential ...
Mohammad Mahmoudi Gomari+11 more
wiley +1 more source
Current landscape of immunotherapy in esophageal cancer: a literature review. [PDF]
Moughnyeh MM+3 more
europepmc +1 more source
Prediction of Postoperative Organ and Lymph Node Recurrences in Esophageal cancer.
Takao Saito+7 more
openalex +2 more sources
Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities
Abstract Copper, one of the essential nutrients for the human body, acts as an electron relay in multiple pathways due to its redox properties. Both deficiencies and excesses of copper lead to cellular fragility. Therefore, it can manifest pro‐ and anti‐cancer properties in tumors. Therefore, it is crucial to clarify the copper activity within the cell.
Dan Shan+13 more
wiley +1 more source